TGA adopts Access Consortium guidance for fast-tracking authorisations of modified COVID-19 vaccines for variants
Australia, Canada, Singapore, Switzerland, United Kingdom
Published
Related content
-
ICMRA statement on the safety of COVID-19 vaccines
This International Coalition of Medicines Regulatory Authorities (ICMRA) statement provides the general public with important information regarding the safety of COVID-19 vaccines, which have now been in use for more than two years. -
Update on effectiveness of monoclonal antibodies against COVID variants
The TGA is aware of concerns about decreased effectiveness of monoclonal antibodies against the COVID-19 caused by emerging SAR-COV-2 variants. At this stage, the regulatory status of the products remain unchanged in Australia. -
TGA provisionally approves Moderna bivalent COVID-19 vaccine for use as a booster dose in adults
TGA provisionally approves Moderna bivalent COVID-19 vaccine for use as a booster dose in adults